AQST (AQST) Stock Price & Analysis
AQST (AQST) fell 0.19% to USD 5.34 as of September 8, 2026 at 06:59 UTC, according to Nexqual real-time market data.
AQST last closed at USD 5.34; the session ranged USD 5.3–5.49 on volume of 2,117,771 shares. Market capitalization is —, with a 52-week range of USD 2.93–7.55 (NGM). Source: Nexqual, September 8, 2026 at 06:59 UTC.
Key Statistics (as of September 8, 2026 at 06:59 UTC)
| Price | USD 5.34 |
|---|---|
| Change | ▼ 0.19% (down) |
| Previous Close | USD 5.34 |
| Open | USD 5.34 |
| Day Range | USD 5.3 – 5.49 |
| 52-Week Range | USD 2.93 – 7.55 |
| Volume | 2,117,771 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (AQST)
Nexqual's technical model rates AQST "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:59 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 69.07 (neutral) |
| vs SMA50 | Above (USD 4.3) |
| MACD | 0.33 (positive) |
From AQST's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SVRA | Savara, Inc. | USD 5.37 | ▼ 1.65% |
| ETON | Eton Pharmaceuticals, Inc. | USD 58.45 | ▼ 5.66% |
| XERS | Xeris Biopharma Holdings, Inc. | USD 8.53 | ▼ 0.58% |
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| ARDX | Ardelyx, Inc. | USD 3.78 | ▼ 0.53% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:59 UTC. This page is informational and not investment advice.